An All‐in‐One Nanozyme for Synergistic Diabetic Wound Therapy: NIR‐Augmented NO Release and Microenvironment Modulation
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xueqin Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioengineering, Henan University of Technology, Zhengzhou, Henan, P. R. China. Hauptthemen laut MEDLINE: Nitric Oxide, Wound Healing, Metal Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Key R&D projects in Henan Province, National Natural Science Foundation of China, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Diabetic wound infection remains a devastating threat to human health, largely due to bacterial colonization and increased antibiotic resistance during conventional treatments, and alternative therapeutic strategies are thus urgent to improve diabetic wound healing. Herein, we developed a multifaceted nanoplatform (CuO@SiO 2 @NO@Au, CSNA NPs) consisting of a cupric oxide (CuO) core, a mesoporous silicon nanoshell loaded with nitric oxide (NO), and in situ grown ultrasmall Au nanoparticles (NPs) for improved diabetic wound treatment. The results showed that the prepared CSNA NPs exhibited remarkable dual‐enzyme mimic activity of glucose oxidase (GOx) and peroxidase (POD), effectively oxidizing glucose to generate gluconic acid, thereby reducing the glucose levels and reversing the acidic wound microenvironment. In addition, the fabricated nanoplatform generated abundant H 2 O 2 , which was converted into highly toxic hydroxyl radical ( · OH), leading to efficient bacterial eradication that was subsequently. Under near‐infrared (NIR) light irradiation, the CSNA nanozyme also triggered the release of NO gas and aided in the removal of bacterial biofilms, collectively improving the wound microenvironment. By integrating chemodynamic therapy (CDT), photothermal therapy, and NO gas therapy, this self‐activatable NIR‐ augmented nanozyme provides a promising antimicrobial strategy for diabetic wound treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Bioengineering, Henan University of Technology, Zhengzhou, Henan, P. R. China.
- Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, P. R. China.
- School of Pharmacy, Henan University, Kaifeng, PR China.
- Henan Provincial People's Hospital, Zhengzhou, P. R. China.
ORCID-Profile: Xueqin Wang
Förderung
- Key R&D projects in Henan Province
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
Zitieren
APA
Wang, X., Chen, H., Liu, C., Wan, M., Zhao, S., Li, N., Duan, S., & Duan, S. (2026). An All‐in‐One Nanozyme for Synergistic Diabetic Wound Therapy: NIR‐Augmented NO Release and Microenvironment Modulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505240
Vancouver
Wang X, Chen H, Liu C, Wan M, Zhao S, Li N, et al. An All‐in‐One Nanozyme for Synergistic Diabetic Wound Therapy: NIR‐Augmented NO Release and Microenvironment Modulation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505240
BibTeX
@article{Wang2026,
author = {Wang, Xueqin and Chen, Hong and Liu, Chuan and Wan, Mengna and Zhao, Shangyi and Li, Na and Duan, Shaofeng and Duan, Shaobo},
title = {An All‐in‐One Nanozyme for Synergistic Diabetic Wound Therapy: NIR‐Augmented NO Release and Microenvironment Modulation},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505240}
}
EUVIMED